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Abstract. In clinical practice, physicians make a series of treatment
decisions over the course of a patient’s disease based on his/her base-
line and evolving characteristics. A dynamic treatment regime is a set
of sequential decision rules that operationalizes this process. Each rule
corresponds to a decision point and dictates the next treatment action
based on the accrued information. Using existing data, a key goal is
estimating the optimal regime, that, if followed by the patient pop-
ulation, would yield the most favorable outcome on average. Q - and
A-learning are two main approaches for this purpose. We provide a de-
tailed account of these methods, study their performance, and illustrate
them using data from a depression study.
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model misspecification, personalized medicine, potential outcomes, se-
quential decision-making.
1. INTRODUCTION
An area of current interest is personalized medi-
cine, which involves making treatment decisions for
an individual patient using all information available
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on the patient, including genetic, physiologic, demo-
graphic and other clinical variables, to achieve the
“best” outcome for the patient given this informa-
tion. In treating a patient with an ongoing disease
or disorder, a clinician makes a series of decisions
based on the patient’s evolving status. A dynamic
treatment regime is a list of sequential decision rules
formalizing this process. Each rule corresponds to a
key decision point in the disease/disorder progres-
sion and takes as input the information on the pa-
tient to that point and outputs the treatment that
s/he should receive from among the available op-
tions. A key step toward personalized medicine is
thus finding the optimal dynamic treatment regime,
that which, if followed by the entire patient popu-
lation, would yield the most favorable outcome on
average.
The statistical problem is to estimate the opti-
mal regime based on data from a clinical trial or
observational study. Q -learning (Q denoting “qual-
ity,” Nahum-Shani et al. (2010), Watkins (1989),
Watkins and Dayan (1992)) and advantage learning
(A-learning, Blatt, Murphy and Zhu (2004), Mur-
phy (2003), Robins (2004)) are two main approaches
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for this purpose and are related to reinforcement
learning methods for sequential decision-making in
computer science. Q -learning is based roughly on
posited regression models for the outcome of inter-
est given patient information at each decision point
and is implemented through a backward recursive
fitting procedure that is related to the dynamic pro-
gramming algorithm (Bather, 2000), a standard ap-
proach for deducing optimal sequential decisions. A-
learning involves the same recursive strategy, but
requires only posited models for the part of the out-
come regression representing contrasts among treat-
ments and for the probability of observed treat-
ment assignment given patient information at each
decision point. As discussed later, this may make
A-learning more robust to model misspecification
than Q -learning for consistent estimation of the op-
timal treatment regime.
Examples of the use of Q - and A-learning and al-
ternative methods to deduce optimal strategies for
treatment of substance abuse, psychiatric disorders,
cancer and HIV infection and for dose adjustment in
response to evolving patient status have been pre-
sented (Rosthøj et al. (2006), Murphy et al., 2007a,
2007b, Henderson, Ansell and Alshibani (2010),
Zhao, Kosorok and Zeng (2009)). Relevant work in-
cludes Thall, Millikan and Sung (2000), Thall, Sung
and Estey (2002), Robins (2004), Moodie, Richard-
son and Stephens (2007), Thall et al. (2007), van der
Laan and Petersen (2007), Robins, Orellana and
Rotnitzky (2008), Almirall, Ten Have and Mur-
phy (2010), Orellana, Rotnitzky and Robins (2010),
Zhang et al. (2012a, 2012b, 2013) and Zhao et al.
(2012, 2013).
The objective of this article is to provide read-
ers interested in an introduction to estimation of
optimal dynamic treatment regimes with a self-
contained, detailed description of an appropriate
statistical framework in which to define formally
an optimal regime, of some of the operational and
philosophical considerations involved, and of Q -
and A-learning methods. Section 2 introduces the
statistical framework, and Sections 3 and 4 dis-
cuss the form of the optimal regime. We describe
and contrast Q - and A-learning in Section 5 and
present systematic empirical studies of their rela-
tive performance and the effects of misspecification
of the postulated models involved in Section 6. The
methods are demonstrated using data from the Se-
quenced Treatment Alternatives to Relieve Depres-
sion (STAR*D, Rush et al. (2004)) study in Sec-
tion 7.
2. FRAMEWORK AND ASSUMPTIONS
Consider the setting of K prespecified, ordered
decision points, indexed by k = 1, . . . ,K, which may
be times or events in the disease or disorder process
that necessitate a treatment decision, where, at each
point, a set of treatment options is available. Assume
that there is a final outcome Y of interest for which
large values are preferred. The outcome may be as-
certained following the Kth decision, as with CD4
T-cell count at a prespecified follow-up time in HIV
infection (Moodie, Richardson and Stephens, 2007),
or may be a function of information accrued over
the entire sequence of decisions, as in Henderson,
Ansell and Alshibani (2010), where the outcome is
the overall proportion of time a measure of blood
clotting speed is kept within a target range in dos-
ing of anticoagulant agents.
In order to define an optimal treatment regime
and discuss its estimation based on data from an
observational study or clinical trial, we define a suit-
able conceptual framework. For simplicity, our pre-
sentation is heuristic. Imagine that there is a su-
perpopulation of patients, denoted by Ω, where one
may view an element ω ∈ Ω as a patient from this
population. We assume that patients in the popu-
lation have been treated according to routine clini-
cal practice for the disease or disorder prior to the
first treatment decision. Consequently, immediately
prior to this first decision, patient ω would present
to the decision-maker with a set of baseline infor-
mation (covariates) denoted by the random vari-
able S1, discussed further below. Thus, S1(ω) is
the value of his/her information immediately prior
to decision 1, taking values s1, say, in a set S1.
Assume that, at each decision point k = 1, . . . ,K,
there is a finite set of all possible treatment op-
tions Ak, with elements ak. We do not consider
the case of continuous treatment and henceforth re-
strict attention to a finite set of options. Denote by
a¯k = (a1, . . . , ak) a possible treatment history that
could be administered through decision k, taking
values in A¯k =A1 × · · · × Ak, where A¯K is the set
of all possible treatment histories a¯K through all K
decisions.
We then define the potential outcomes (Robins,
1986)
W ∗ = {S∗2(a1), S
∗
3(a¯2), . . . , S
∗
k(a¯k−1), . . . ,
(1)
S∗K(a¯K−1), Y
∗(a¯K) for all a¯K ∈ A¯K}.
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In (1), S∗k(a¯k−1)(ω) denotes the value of covari-
ate information that would arise between decisions
k − 1 and k for a patient ω ∈ Ω in the hypothet-
ical situation that s/he were to have previously
received treatment history a¯k−1, taking values sk
in a set Sk, k = 2, . . . ,K. Similarly, Y
∗(a¯K)(ω) is
the hypothetical outcome that would result for ω
were s/he to have been administered the full set
of K treatments in a¯K . This notation implies that,
for random variables such as S∗k(a¯k−1), a¯k−1 is an
index representing prior treatment history. Write
S¯∗k(a¯k−1) = {S1, S
∗
2(a1), . . . , S
∗
k(a¯k−1)}, k = 1, . . . ,K,
where S¯∗k(a¯k−1)(ω) takes values s¯k in S¯k = S1×· · ·×
Sk; this definition includes the baseline covariate S1
and is taken equal to S1 when k = 1. The elements
of the S¯∗k(a¯k−1) and Y
∗(a¯K) may be discrete or con-
tinuous; in what follows, for simplicity, we take these
random variables to be discrete, but the results hold
more generally.
A dynamic treatment regime d= (d1, . . . , dK) is a
set of rules that forms an algorithm for treating a
patient over time; it is “dynamic” because treatment
is determined based on a patient’s previous history.
At the kth decision point, the kth rule dk(s¯k, a¯k−1),
say, takes as input the patient’s realized covariate
and treatment history prior to the kth treatment de-
cision and outputs a value ak ∈ Ψk(s¯k, a¯k−1) ⊆ Ak;
for k = 1, there is no prior treatment (a0 is null),
and we write d1(s1) and Ψ1(s1). Here, Ψk(s¯k, a¯k−1)
is a specified set of possible treatment options for
a patient with realized history (s¯k, a¯k−1), discussed
further below. Accordingly, although we suppress
this in the notation for brevity, the definition of a
dynamic treatment regime we now present depends
on the specified Ψk(s¯k, a¯k−1), k = 1, . . . ,K. Because
dk(s¯k, a¯k−1) ∈Ψk(s¯k, a¯k−1)⊆Ak, dk need only map
a subset of S¯k×A¯k−1 to Ak. We define these subsets
recursively as
Γk = {(s¯k, a¯k−1) ∈ S¯k × A¯k−1 satisfying
(i) aj ∈Ψj(s¯j, a¯j−1), j = 1, . . . , k− 1 and(2)
(ii) pr{S¯∗k(a¯k−1) = s¯k}> 0}, k = 1, . . . ,K,
determined by Ψ= (Ψ1, . . . ,ΨK). The Γk contain all
realizations of covariate and treatment history con-
sistent with having followed such Ψ-specific regimes
to decision k. Define the class D of (Ψ-specific) dy-
namic treatment regimes to be the set of all d for
which dk, k = 1, . . . ,K, is a mapping from Γk into
Ak satisfying dk(s¯k, a¯k−1) ∈ Ψk(s¯k, a¯k−1) for every
(s¯k, a¯k−1) ∈ Γk.
Specification of the Ψk(s¯k, a¯k−1), k = 1, . . . ,K,
is dictated by the scientific setting and objectives.
Some treatment options may be unethical or im-
possible for patients with certain histories, making
it natural to restrict the set of possible options for
such patients. In the context of public health policy,
the focus may be on regimes involving only treat-
ment options that are less costly or widely available
unless a patient’s condition is especially serious, as
reflected in his/her covariate information. In what
follows, we assume that a particular fixed set Ψ is
specified, and by an optimal regime we mean an op-
timal regime within the class of corresponding Ψ-
specific regimes.
An optimal regime should represent the “best”
way to intervene to treat patients in Ω. To for-
malize, for any d ∈ D, writing d¯k = (d1, . . . , dk),
k = 1, . . . ,K, d¯K = d, define the potential outcomes
associated with d as {S∗2(d1), . . . , S
∗
k(d¯k−1), . . . ,
S∗K(d¯K−1), Y
∗(d)} such that, for any ω ∈ Ω, with
S1(ω) = s1,
d1(s1) = u1,
S∗2(d1)(ω) = S
∗
2(u1)(ω) = s2,
d2(s¯2, u1) = u2, . . . ,
dK−1(s¯K−1, u¯K−2) = uK−1,(3)
S∗K(d¯K−1)(ω) = S
∗
K(u¯K−1)(ω) = sK ,
dK(s¯K , u¯K−1) = uK ,
Y ∗(d)(ω) = Y ∗(u¯K)(ω) = y.
The index d¯k−1 emphasizes that S
∗
k(d¯k−1)(ω) rep-
resents the covariate information that would arise
between decisions k − 1 and k were patient ω to
receive the treatments sequentially dictated by the
first k − 1 rules in d. Similarly, Y ∗(d)(ω) is the fi-
nal outcome that ω would experience if s/he were to
receive the K treatments dictated by d.
With these definitions, the expected outcome in
the population if all patients with initial state S1 =
s1 were to follow regime d is E{Y
∗(d)|S1 = s1}. An
optimal regime, dopt ∈D, say, satisfies
E{Y ∗(d)|S1 = s1} ≤E{Y
∗(dopt)|S1 = s1}
(4)
for all d ∈D and all s1 ∈ S1.
Because (4) is true for any fixed s1, in fact,
E{Y ∗(d)} ≤ E{Y ∗(dopt)} for any d ∈D. In Section 3,
we give the form of dopt satisfying (4).
Alternative specifications of Ψ may lead to dif-
ferent classes of regimes across which the optimal
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regime may differ. We emphasize that the defini-
tion (4) is predicated on the particular set Ψ, and
hence class D, of interest. In principle, the class D
of interest is conceived based on scientific or policy
objectives without reference to data available from
a particular study.
Of course, potential outcomes for a given patient
for all d ∈ D are not observed. Thus, the goal is to
estimate dopt in (4) using data from a study car-
ried out on a random sample of n patients from
Ω that record baseline and evolving covariate in-
formation and treatments actually received. De-
note these available data as independent and iden-
tically distributed (i.i.d.) time-ordered random vari-
ables (S1i,A1i, . . . , SKi,AKi, Yi), i = 1, . . . , n, on Ω.
Here, S1 is as before; Sk, k = 2, . . . ,K, is covari-
ate information recorded between decisions k − 1
and k, taking values sk ∈ Sk; Ak, k = 1, . . . ,K, is
the recorded, observed treatment assignment, taking
values ak ∈Ak; and Y is the observed outcome, tak-
ing values y ∈ Y . As above, define S¯k = (S1, . . . , Sk)
and A¯k = (A1, . . . ,Ak), k = 1, . . . ,K, taking values
s¯k ∈ S¯k and a¯k ∈ A¯k.
The available data may arise from an obser-
vational study involving n participants randomly
sampled from the population; here, treatment as-
signment takes place according to routine clinical
practice in the population. Alternatively, the data
may arise from an intervention study. A clinical
trial design that has been advocated for collect-
ing data suitable for estimating optimal treatment
regimes is that of a so-called sequential multiple-
assignment randomized trial (SMART, Lavori and
Dawson (2000), Murphy (2005)). In a SMART in-
volving K pre-specified decision points, each partic-
ipant is randomized at each decision point to one
of a set of treatment options, where, at the kth de-
cision, the randomization probabilities may depend
on past realized information s¯k, a¯k−1.
In order to use the observed data from either type
of study to estimate an optimal regime, several as-
sumptions are required. As is standard, we make
the consistency assumption (e.g., Robins (1994))
that the covariates and outcomes observed in the
study are those that potentially would be seen un-
der the treatments actually received, that is, Sk =
S∗k(A¯k−1), k = 2, . . . ,K, and Y = Y
∗(A¯K). We also
make the stable unit treatment value assumption
(Rubin, 1978), which ensures that a patient’s covari-
ates and outcome are unaffected by how treatments
are allocated to her/him and other patients. The
critical assumption of no unmeasured confounders,
also referred to as the sequential randomization
assumption (Robins, 1994), must be satisfied. A
strong version of this assumption states that Ak
is conditionally independent of W ∗ in (1) given
{S¯k, A¯k−1}, k = 1, . . . ,K, where A0 is null, written
Ak⊥W
∗|S¯k, A¯k−1. In a SMART, this assumption is
satisfied by design; in an observational study, it is
unverifiable from the observed data. The strong ver-
sion is sufficient for identification of the distribution
of not only Y ∗(a¯K) but of the joint distribution of
Y ∗(a¯K) and S¯
∗
K(a¯K−1) and allows the results of Sec-
tion 4 to hold. Although in the population patients
and their providers may make decisions based only
on past covariate information available to them, the
issue is whether or not all of the information that is
related to treatment assignment and future covari-
ates and outcome is recorded in the Sk; see Robins
[(2004), Sections 2–3] for discussion and a relaxation
of the version of the sequential randomization as-
sumption given here. We assume henceforth that
these assumptions hold.
Whether or not it is possible to estimate dopt from
the available data is predicated on the treatment
options in Ψk(s¯k, a¯k−1), k = 1, . . . ,K, being rep-
resented in the data. For a prospectively-designed
SMART, ordinarily, Ψ defining the class D of in-
terest would dictate the design. At decision k,
subjects would be randomized to the options in
Ψk(s¯k, a¯k−1), satisfying this condition. If the data
are from an observational study, all treatment op-
tions in Ψk(s¯k, a¯k−1) at each decision k must have
been assigned to some patients. That is, if we de-
fine recursively Γmax1 = {s1 ∈ S1 : pr(S1 = s1) > 0},
Ψmax1 (s1) = {a1 ∈ A1 : pr(A1 = a1|S1 = s1) > 0 for
all s1 ∈ Γ
max
1 }, Γ
max
k = [(s¯k, a¯k−1) ∈ S¯k × A¯k−1 sat-
isfying (i) aj ∈ Ψ
max
j (s¯j, a¯j−1), j = 1, . . . , k − 1, and
(ii) pr{S¯∗k(a¯k−1) = s¯k} > 0], Ψ
max
k (s¯k, a¯k−1) = {ak ∈
Ak : pr(Ak = ak|S¯k = s¯k, A¯k−1 = a¯k−1) > 0 for all
(s¯k, a¯k−1) ∈ Γ
max
k }, k = 2, . . . ,K, we must have
Ψk(s¯k, a¯k−1) ⊆ Ψ
max
k (s¯k, a¯k−1), k = 1, . . . ,K. The
class of regimes dictated by Ψmax = (Ψmax1 , . . . ,Ψ
max
K )
is the largest that can be considered based on the
data, sometimes referred to as the class of “feasible
regimes” (Robins, 2004). If this inclusion condition
does not hold for all k = 1, . . . ,K, dopt cannot be
estimated from the data, and the class of regimes
D of interest must be reevaluated or another data
source found.
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3. OPTIMAL TREATMENT REGIMES
Q - and A-learning are two approaches to estimat-
ing dopt satisfying (4) under the foregoing frame-
work. Both involve recursive fitting algorithms; the
main distinguishing feature is the form of the under-
lying models. To appreciate the rationale, one must
understand how dopt is determined via dynamic pro-
gramming, also known as backward induction. We
demonstrate the formulation of dopt in terms of the
potential outcomes and then show how dopt may be
expressed in terms of the observed data under as-
sumptions including those in Section 2. We some-
times highlight dependence on specific elements of
quantities such as a¯k, writing, for example, a¯k as
(a¯k−1, ak).
At the Kth decision point, for any s¯K ∈ S¯K ,
a¯K−1 ∈ A¯K−1 for which (s¯K , a¯K−1) ∈ ΓK , define
d
(1)opt
K (s¯K , a¯K−1)
= arg max
aK∈ΨK(s¯K ,a¯K−1)
E{Y ∗(a¯K−1, aK)|(5)
S¯∗K(a¯K−1) = s¯K},
V
(1)
K (s¯K , a¯K−1)
= max
aK∈ΨK(s¯K ,a¯K−1)
E{Y ∗(a¯K−1, aK)|(6)
S¯∗K(a¯K−1) = s¯K}.
For k =K − 1, . . . ,1 and any s¯k ∈ S¯k, a¯k−1 ∈ A¯k−1
for which (s¯k, a¯k−1) ∈ Γk, which clearly holds if
(s¯K , a¯K−1) ∈ ΓK , let
d
(1)opt
k (s¯k, a¯k−1)
= arg max
ak∈Ψk(s¯k,a¯k−1)
E[V
(1)
k+1{s¯k, S
∗
k+1(a¯k−1, ak),(7)
a¯k−1, ak}|S¯
∗
k(a¯k−1) = s¯k],
V
(1)
k (s¯k, a¯k−1)
= max
ak∈Ψk(s¯k,a¯k−1)
E[V
(1)
k+1{s¯k, S
∗
k+1(a¯k−1, ak),(8)
a¯k−1, ak}|S¯
∗
k(a¯k−1) = s¯k];
thus, for s1 ∈ S1,
d
(1)opt
1 (s1)
= arg max
a1∈Ψ1(s1)
E[V
(1)
2 {s1, S
∗
2(a1), a1}|S1 = s1],
V
(1)
1 (s1)
= max
a1∈Ψ1(s1)
E[V
(1)
2 {s1, S
∗
2(a1), a1}|S1 = s1].
Conditional expectations are well defined by (2)(ii).
Clearly, d(1)opt = (d
(1)opt
1 , . . . , d
(1)opt
K ) is a treat-
ment regime, as it comprises a set of rules that
uses patient information to assign treatment from
among the options in Ψ. The superscript (1) indi-
cates that d(1)opt provides K rules for a patient pre-
senting prior to decision 1 with baseline information
S1 = s1; Section 4 considers optimal treatment of
patients presenting at subsequent decisions after re-
ceiving possibly suboptimal treatment at prior deci-
sions. Note that d(1)opt is defined in a backward iter-
ative fashion. At decision K, (5) gives the treatment
that maximizes the expected potential final outcome
given the prior potential information, and (6) is the
maximum achieved. At decisions k = K − 1, . . . ,1,
(7) gives the treatment that maximizes the expected
outcome that would be achieved if subsequent opti-
mal rules already defined were followed henceforth.
In Section A.1 of the supplemental article [Schulte
et al. (2014)], we show that d(1)opt defined in (5)–
(8) is an optimal treatment regime in the sense of
satisfying (4).
The foregoing developments express optimal regi-
mes in terms of the distribution of potential out-
comes. If an optimal regime is to be identifiable, it
must be possible under the assumptions in Section 2
to express d(1)opt in terms of the distribution of the
observed data. To this end, define
QK(s¯K , a¯K) = E(Y |S¯K = s¯K , A¯K = a¯K),(9)
doptK (s¯K , a¯K−1)
(10)
= arg max
aK∈ΨK(s¯K ,a¯K−1)
QK(s¯K , a¯K−1, aK),
VK(s¯K , a¯K−1)
(11)
= max
aK∈ΨK(s¯K ,a¯K−1)
QK(s¯K , a¯K−1, aK),
and for k =K − 1, . . . ,1, define
Qk(s¯k, a¯k)
(12)
= E{Vk+1(s¯k, Sk+1, a¯k)|S¯k = s¯k, A¯k = a¯k},
doptk (s¯k, a¯k−1)
(13)
= arg max
ak∈Ψk(s¯k,a¯k−1)
Qk(s¯k, a¯k−1, ak),
Vk(s¯k, a¯k−1) = max
ak∈Ψk(s¯k,a¯k−1)
Qk(s¯k, a¯k−1, ak).(14)
The expressions in (9)–(14) are well defined un-
der assumptions we discuss next. In (9) and (12),
Qk(s¯k, a¯k) are referred to as “Q -functions,” viewed
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as measuring the “quality” associated with using
treatment ak at decision k given the history up to
that decision and then following the optimal regime
thereafter. The “value functions” Vk(s¯k, a¯k−1) in
(11) and (14) reflect the “value” of a patient’s his-
tory s¯k, a¯k−1 assuming that optimal decisions are
made in the future. We emphasize that the doptk ,
k = 1, . . . ,K, defined in (9)–(14) may not be op-
timal unless the sequential randomization, consis-
tency and positivity assumptions hold.
As in Section 2, the treatment options in Ψ must
be represented in the data, that is, Ψk(s¯k, a¯k−1) ⊆
Ψmaxk (s¯k, a¯k−1), k = 1, . . . ,K, in order to estimate an
optimal regime. Formally, this implies that
pr(Ak = ak|S¯k = s¯k, A¯k−1 = a¯k−1)> 0
(15)
if (s¯k, a¯k−1) ∈ Γk and ak ∈Ψk(s¯k, a¯k−1)
for all k = 1, . . . ,K. In Section A.2 of the sup-
plemental article [Schulte et al. (2014)], under the
consistency and sequential randomization assump-
tions and the positivity assumption (15), we show
that, for any (s¯k, a¯k−1) ∈ Γk and ak ∈Ψk(s¯k, a¯k−1),
k = 1, . . . ,K,
pr(S¯k = s¯k, A¯k = a¯k)> 0,(16)
pr(Sk+1 = sk+1|S¯k = s¯k, A¯k = a¯k)
(17)
= pr{S∗k+1(a¯k) = sk+1|S¯k = s¯k, A¯k−1 = a¯k−1}
= pr{S∗k+1(a¯k) = sk+1|S¯j = s¯j, A¯j−1 = a¯j−1,
(18)
S∗j+1(a¯j) = sj+1, . . . , S
∗
k(a¯k−1) = sk},
for j = 1, . . . , k, where (18) with j = k is the same
as the right-hand side of (17), SK+1 = Y and
S∗K+1(a¯K) = Y
∗(a¯K), and when j = 1 the condi-
tioning events do not involve treatment. By (16),
the quantities in (9)–(14) are well defined. Under
(17)–(18), the conditional distributions of the ob-
served data involved in (9)–(14) are the same as the
conditional distributions of the potential outcomes
involved in (5)–(8). It follows that
d
(1)opt
k (s¯k, a¯k−1) = d
opt
k (s¯k, a¯k−1),
(19)
V
(1)
k (s¯k, a¯k−1) = Vk(s¯k, a¯k−1),
for (s¯k, a¯k−1) ∈ Γk, k = 1, . . . ,K. The equivalence in
(19) shows that, under the consistency, sequential
randomization and positivity assumptions, an op-
timal treatment regime in the (Ψ-specific) class of
interest D may be obtained using the distribution
of the observed data.
There may not be a unique dopt. At any decision
k, if there is more than one possible option ak max-
imizing the Q -function, then any rule doptk yielding
one of these ak defines an optimal regime.
4. OPTIMAL “MIDSTREAM” TREATMENT
REGIME
In Section 3 we define an (Ψ-specific) optimal
treatment regime starting at decision point 1 and
elucidate conditions under which it may be esti-
mated using data from a clinical or observational
study collected through all K decisions on a sample
from the patient population. The goal is to estimate
the optimal regime and implement it in new such
patients presenting at the first decision.
In routine clinical practice, however, a new pa-
tient may be encountered subsequent to decision
point 1. For definiteness, suppose a new patient
presents “midstream,” immediately prior to the
ℓth decision point, ℓ = 2, . . . ,K. A natural ques-
tion is how to treat this patient optimally hence-
forth. For such a patient, the first ℓ − 1 treat-
ment decisions presumably have been made accord-
ing to routine practice, and s/he has a realized
past history that may be viewed as realizations of
random variables (S
(P )
1 ,A
(P )
1 , . . . , S
(P )
ℓ−1,A
(P )
ℓ−1, S
(P )
ℓ ).
Here, A
(P )
k , k = 1, . . . , ℓ − 1, represent the treat-
ments received by such a patient according to the
treatment assignment mechanism governing routine
practice; and S
(P )
k , k = 1, . . . , ℓ − 1, denote covari-
ate information collected up to the ℓth decision.
Write A¯
(P )
k = (A
(P )
1 , . . . ,A
(P )
k ), k = 1, . . . , ℓ− 1, and
S¯
(P )
k = (S
(P )
1 , . . . , S
(P )
k ), k = 1, . . . , ℓ.
As Ak denotes the set of all possible treatment
options at decision k, A¯
(P )
ℓ−1 takes on values a¯ℓ−1 ∈
A¯ℓ−1. To define Ψ-specific regimes starting at de-
cision ℓ, at the least, S
(P )
k must contain the same
information as Sk in the data, k = 1, . . . , ℓ. Because
the available data dictate the covariate information
incorporated in the class of regimes D, if S
(P )
k con-
tains additional information, it cannot be used in
the context of such regimes. We thus take S
(P )
k and
Sk to contain the same information, stated formally
as the consistency assumption S
(P )
k = S
∗
k(A¯
(P )
k−1), k =
1, . . . , ℓ. Moreover, we can only consider treating new
patients with realized histories (s¯ℓ, a¯ℓ−1) that are
contained in Γℓ, that is, that could have resulted
from following a Ψ-specific regime through decision
ℓ−1. If the data arise from a SMART including only
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a subset of the treatments employed in practice, this
may not hold.
We thus desire rules d
(ℓ)
k (s¯k, a¯k−1), k = ℓ, ℓ +
1, . . . ,K, say, that dictate how to treat such mid-
stream patients presenting with realized past his-
tory (S¯
(P )
ℓ , A¯
(P )
ℓ−1) = (s¯ℓ, a¯ℓ−1). In the following, we
regard (s¯ℓ, a¯ℓ−1) as fixed, corresponding to the par-
ticular new patient. Let Γ
(ℓ)
k be all elements of Γk
with (s¯ℓ, a¯ℓ−1) fixed at the values for the given new
patient. Write d(ℓ) = (d
(ℓ)
ℓ , d
(ℓ)
ℓ+1, . . . , d
(ℓ)
K ) to denote
regimes starting at the ℓth decision point, and define
the class D(ℓ) of all such regimes to be the set of all
d(ℓ) for which d
(ℓ)
k (s¯k, a¯k−1) = ak for (s¯k, a¯k−1) ∈ Γ
(ℓ)
k
and ak ∈ Ψk(s¯k, a¯k−1) for k = ℓ, . . . ,K. Then, by
analogy to (4), we seek d(ℓ)opt satisfying
E{Y ∗(a¯ℓ−1, d
(ℓ))|S¯
(P )
ℓ = s¯ℓ, A¯
(P )
ℓ−1 = a¯ℓ−1}
(20)
≤ E{Y ∗(a¯ℓ−1, d
(ℓ)opt)|S¯
(P )
ℓ = s¯ℓ, A¯
(P )
ℓ−1 = a¯ℓ−1}
for all d(ℓ) ∈D(ℓ) and s¯ℓ ∈ S¯ℓ, a¯ℓ−1 ∈ A¯ℓ−1 for which
pr(S¯
(P )
ℓ = s¯ℓ, A¯
(P )
ℓ−1 = a¯ℓ−1) > 0. Viewing this as a
problem of making K − ℓ + 1 decisions at deci-
sion points ℓ, ℓ+ 1, . . . ,K, with initial state S¯
(P )
ℓ =
s¯ℓ, A¯
(P )
ℓ−1 = a¯ℓ−1, by an argument analogous to that
in Section A.1 of the supplemental article [Schulte
et al. (2014)] for ℓ = 1 and initial state S1 = s1,
letting Vℓ,k = {S¯
(P )
ℓ = s¯ℓ, A¯
(P )
ℓ−1 = a¯ℓ−1, S
∗
ℓ+1(a¯ℓ) =
sℓ+1, . . . , S
∗
k(a¯k−1) = sk}, it may be shown that
d(ℓ)opt satisfying (20) is given by
d
(ℓ)opt
K (s¯K , a¯K−1)
(21)
= arg max
aK∈ΨK(s¯K ,a¯K−1)
E{Y ∗(a¯K−1, aK)|Vℓ,K},
V
(ℓ)
K (s¯K , a¯K−1)
(22)
= max
aK∈ΨK(s¯K ,a¯K−1)
E{Y ∗(a¯K−1, aK)|Vℓ,K}
for any s¯K ∈ S¯K , a¯K−1 ∈ A¯K−1 for which (s¯K ,
a¯K−1) ∈ Γ
(ℓ)
K ; and, for k =K − 1, . . . , ℓ,
d
(ℓ)opt
k (s¯k, a¯k−1)
= arg max
ak∈Ψk(s¯k ,a¯k−1)
E[V
(ℓ)
k+1{s¯k,(23)
S∗k+1(a¯k−1, ak), a¯k−1, ak}|Vℓ,k],
V
(ℓ)
k (s¯k, a¯k−1)
= max
ak∈Ψk(s¯k,a¯k−1)
E[V
(ℓ)
k+1{s¯k,(24)
S∗k+1(a¯k−1, ak), a¯k−1, ak}|Vℓ,k]
for any s¯k ∈ S¯k, a¯k−1 ∈ A¯k−1 for which (s¯k, a¯k−1) ∈
Γ
(ℓ)
k , so that
d
(ℓ)opt
ℓ (s¯ℓ, a¯ℓ−1)
= arg max
aℓ∈Ψℓ(s¯ℓ,a¯ℓ−1)
E[V
(ℓ)
ℓ+1{s¯ℓ, S
∗
ℓ+1(a¯ℓ−1, aℓ),
a¯ℓ−1, aℓ}|S¯
(P )
ℓ = s¯ℓ, A¯
(P )
ℓ−1 = a¯ℓ−1].
Comparison of (5)–(8) to (21)–(24) shows that the
ℓth to Kth rules of the optimal regime d(1)opt that
would be followed by a patient presenting at the first
decision are not necessarily the same as those of the
optimal regime d(ℓ)opt that would be followed by a
patient presenting at the ℓth decision. In particu-
lar, noting that the conditioning sets in (5)–(8) are
V1,K and V1,k, the rules are ℓ-dependent through de-
pendence of the conditioning sets Vℓ,k, ℓ= 1, . . . ,K,
k = ℓ, . . . ,K, on ℓ. However, we now demonstrate
that these rules coincide under certain conditions.
Make the consistency, sequential randomization
and positivity (15) assumptions on the available
data required to show (19) in Section 3, along with
the consistency assumption on the S
(P )
k above and
the sequential randomization assumption A
(P )
k ⊥W
∗|
S¯
(P )
k , A¯
(P )
k−1, k = 1, . . . , ℓ− 1, which ensures that the
S¯
(P )
k include all information related to treatment
assignment and future covariates and outcome up
to decision ℓ. Note that (21)–(24) are expressed in
terms of the conditional distributions pr{S∗k+1(a¯k) =
sk+1|S¯
(P )
ℓ = s¯ℓ, A¯
(P )
ℓ−1 = a¯ℓ−1, S
∗
ℓ+1(a¯ℓ) = sℓ, . . . ,
S∗k(a¯k−1) = sk}, k = ℓ, . . . ,K. We can then use (18)
with j = ℓ to deduce that these conditional distribu-
tions can be written equivalently as pr{S∗k+1(a¯k) =
sk+1|S¯
∗
k(a¯k−1) = s¯k}, k = ℓ, . . . ,K, so solely in terms
of the distribution of the potential outcomes. By
(17) and (18) with j = 1, this can be written as
pr(Sk+1 = sk+1|S¯k = s¯k, A¯k = a¯k). This shows that
(21)–(24) can be reexpressed in terms of the ob-
served data, so that, for (s¯k, a¯k−1) ∈ Γk for ℓ =
1, . . . ,K and k = ℓ, . . . ,K,
d
(ℓ)opt
k (s¯k, a¯k−1) = d
opt
k (s¯k, a¯k−1),
(25)
V
(ℓ)
k (s¯k, a¯k−1) = Vk(s¯k, a¯k−1).
Note that (25) subsumes (19) when ℓ= 1. The equiv-
alence in (25) demonstrates not only that an op-
timal treatment regime can be obtained using the
distribution of the observed data but also that the
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corresponding rules dictating treatment do not de-
pend on ℓ under these assumptions. Thus, the single
set of rules dopt = (dopt1 , . . . , d
opt
K ) defined in (10) and
(13) is relevant regardless of when a patient presents.
That is, treatment at the ℓth decision point for a pa-
tient who presents at decision 1 and has followed the
rules in dopt to that point would be determined by
doptℓ evaluated at his/her history up to that point,
as would treatment for a subject presenting for the
first time immediately prior to decision ℓ. See Robins
[(2004), pages 305–306] for more discussion.
5. Q- AND A-LEARNING
5.1 Q-Learning
From (10), (13) and (19), an optimal (Ψ-specific)
regime dopt may be represented in terms of the Q -
functions (9), (12). Thus, estimation of dopt based
on i.i.d. data (S1i,A1i, . . . , SKi,AKi, Yi), i= 1, . . . , n,
may be accomplished via direct modeling and fitting
of the Q -functions. This is the approach underly-
ing Q -learning. Specifically, one may posit models
Qk(s¯k, a¯k; ξk), say, for k =K,K − 1, . . . ,1, each de-
pending on a finite-dimensional parameter ξk. The
models may be linear or nonlinear in ξk and include
main effects and interactions in the elements of s¯k
and a¯k.
Estimators ξ̂k may be obtained in a backward iter-
ative fashion for k =K,K − 1, . . . ,1 by solving suit-
able estimating equations [e.g., ordinary (OLS) or
weighted (WLS) least squares]. Assuming the lat-
ter, for k =K, letting V˜(K+1)i = Yi, one would first
solve
n∑
i=1
∂QK(S¯Ki, A¯Ki; ξK)
∂ξK
Σ−1K (S¯Ki, A¯Ki)
(26)
×{V˜(K+1)i −QK(S¯Ki, A¯Ki; ξK)}= 0
in ξK to obtain ξ̂K , where ΣK(s¯K , a¯K) is a working
variance model. Substituting the model QK(s¯K , a¯K ;
ξK) in (10) and accordingly writing d
opt
K (s¯K , a¯K−1;
ξK), substituting ξ̂K for ξK , yields an estimator for
the optimal treatment choice at decision K for a
patient with past history S¯K = s¯K , A¯K−1 = a¯K−1.
With ξ̂K in hand, one would form for each i, based
on (11), V˜Ki = maxaK∈ΨK(S¯Ki,A¯(K−1)i)QK(S¯Ki,
A¯(K−1)i, aK ; ξ̂K). To obtain ξ̂K−1, setting k =K−1,
based on (12) and letting Σk(s¯k, a¯k) be a working
variance model, one would then solve for ξk,
n∑
i=1
∂Qk(S¯ki, A¯ki; ξk)
∂ξk
Σ−1k (S¯ki, A¯ki)
(27)
× {V˜(k+1)i −Qk(S¯ki, A¯ki; ξk)}= 0.
The corresponding doptK−1(s¯K−1, a¯K−2; ξ̂K−1) yields
an estimator for the optimal treatment choice at de-
cision K − 1 for a patient with past history S¯K−1 =
s¯K−1, A¯K−2 = a¯K−2, assuming s/he will take the
optimal treatment at decision K. One would con-
tinue this process in the obvious fashion for k =K−
2, . . . ,1, forming V˜ki = maxak∈Ψk(S¯ki,A¯(k−1)i)Qk(S¯ki,
A¯(k−1)i, ak; ξ̂k), and solving equations of form (27)
to obtain ξ̂k and corresponding d
opt
k (s¯k, a¯k−1; ξ̂k).
We may now summarize the estimated optimal
regime as d̂optQ = (d̂
opt
Q,1, . . . , d̂
opt
Q,K), where
d̂optQ,1(s1) = d
opt
1 (s1; ξ̂1),
d̂optQ,k(s¯k, a¯k−1) = d
opt
k (s¯k, a¯k−1; ξ̂k),(28)
k = 2, . . . ,K.
It is important to recognize that, even under the
sequential randomization assumption, the estimated
regime (28) may not be a consistent estimator for
the true optimal regime unless all the models for
the Q -functions are correctly specified.
We illustrate the approach for K = 2, where at
each decision there are two possible treatment op-
tions coded as 0 and 1, that is, Ψ1(s1) = A1 =
{0,1} for all s1 and Ψ2(s¯2, a1) = A2 = {0,1} for
all s¯2 and a1 ∈ {0,1}. Let H1 = (1, s
T
1 )
T and H2 =
(1, sT1 , a1, s
T
2 )
T . As in many modeling contexts, it is
standard to adopt linear models for the Q-functions;
accordingly, consider the models
Q1(s1, a1; ξ1) =H
T
1 β1 + a1(H
T
1 ψ1),
(29)
Q2(s¯2, a¯2; ξ2) =H
T
2 β2 + a2(H
T
2 ψ2),
where ξk = (β
T
k , ψ
T
k )
T , k = 1,2. In (29), Q2(s¯2, a¯2; ξ2)
is a model for E(Y |S¯2 = s¯2, A¯2 = a¯2), a standard re-
gression problem involving observable data, whereas
Q1(s1, a1; ξ1) is a model for the conditional expecta-
tion of V2(s¯2, a1) = maxa2∈{0,1}E(Y |S¯2 = s2,A1 =
a1,A2 = a2) given S1 = s1 and A1 = a1, which
is an approximation to a complex true relation-
ship; see Section 5.3. Under (29), V2(s¯2, a1; ξ2) =
maxa2∈{0,1}Q2(s¯2, a1, a2; ξ2) = H
T
2 β2 + (H
T
2 ψ2) ×
I(HT2 ψ2 > 0) and V1(s1; ξ1) = maxa1∈{0,1}Q1(s1, a1;
Q- AND A-LEARNING METHODS FOR OPTIMAL REGIMES 9
ξ1) =H
T
1 β1+(H
T
1 ψ1)I(H
T
1 ψ1 > 0). Substituting the
Q -functions in (29) in (10) and (13) then yields
dopt1 (s1; ξ1) = I(H
T
1 ψ1 > 0) and d
opt
2 (s¯2, a1; ξ2) =
I(HT2 ψ2 > 0).
We have presented (26) and (27) in the conven-
tional WLS form, with leading term in the sum-
mand ∂/∂ξkQk(S¯ki, A¯ki; ξk)Σ
−1
k (S¯ki, A¯ki); taking Σk
to be a constant yields OLS. At the Kth deci-
sion, with responses Yi, standard theory implies that
this is the optimal leading term when var(Y |S¯K =
sK , A¯K = aK) = ΣK(s¯K , a¯K), yielding the (asymp-
totically) efficient estimator for ξK . For k <K, with
“responses” V˜(k+1)i, this theory may no longer ap-
ply, however, deriving the optimal leading term in-
volves considerable complication. Accordingly, it is
standard to fit the posited models Qk(s¯k, a¯k; ξk)
via OLS or WLS; some authors define Q -learning
as using OLS (Chakraborty, Murphy and Strecher,
2010). The choice may be dictated by apparent rel-
evance of the homoscedasticity assumption on the
V˜(k+1)i, k =K,K − 1, . . . ,1, and whether or not lin-
ear models are sufficient to approximate the rela-
tionships may also be evaluated; see Section 5.3.
5.2 A-Learning
Advantage learning (A-learning, Blatt, Murphy
and Zhu (2004)) is a term used to describe a class
of alternative methods to Q -learning predicated on
the fact that the entire Q -function need not be spec-
ified to estimate the optimal regime. For simplicity,
we consider here only the case of two treatment op-
tions coded as 0 and 1 at each decision, that is,
Ψk(s¯k, a¯k−1) =Ak = {0,1}, k = 1, . . . ,K.
To fix ideas, consider (29). Note that dopt1 (s1; ξ1)
implied by (29) depends only on HT1 ψ1 = Q1(s1,1;
ξ1) − Q1(s1,0; ξ1); likewise, d
opt
2 (s¯2, a1; ξ2) depends
only on HT2 ψ2 = Q2(s¯2, a1,1; ξ2) − Q2(s¯2, a1,0; ξ2).
This reflects the general result that, for purposes
of deducing the optimal regime, for each k =
1, . . . ,K, it suffices to know the contrast func-
tion Ck(s¯k, a¯k−1) =Qk(s¯k, a¯k−1,1)−Qk(s¯k, a¯k−1,0).
This can be appreciated by noting that any arbi-
trary Qk(s¯k, a¯k) may be written as hk(s¯k, a¯k−1) +
akCk(s¯k, a¯k−1), where hk(s¯k, a¯k−1) =Qk(s¯k, a¯k−1,0),
so that Qk(s¯k, a¯k−1, ak) is maximized by taking
ak = I{Ck(s¯k, a¯k−1)> 0}; and the maximum itself is
the expression hk(s¯k, a¯k−1) + Ck(s¯k, a¯k−1)I{Ck(s¯k,
a¯k−1) > 0}. In the case of two treatment options
we consider here, the contrast function is also
referred to as the optimal-blip-to-zero function
(Robins, 2004, Moodie, Richardson and Stephens,
2007). Murphy (2003) considers the expression
Ck(S¯k, A¯k−1)[I{Ck(S¯k, A¯k−1)> 0}−Ak], referred to
as the advantage or regret function, as it represents
the “advantage” in response incurred if the opti-
mal treatment at the kth decision were given rela-
tive to that actually received (or, equivalently, the
“regret” incurred by not using the optimal treat-
ment). See Robins (2004) and Moodie, Richardson
and Stephens (2007) for discussion of the relation-
ship between regrets and optimal blip functions in
this and settings other than binary treatment op-
tions.
We discuss here an A-learning method based on
explicit modeling of the contrast functions, which
we refer to as contrast-based A-learning. This ap-
proach is implemented via recursive solution of cer-
tain estimating equations given below developed by
Robins (2004), often referred to as g-estimation. See
Moodie, Richardson and Stephens (2007) and the
supplementary material to Zhang et al. (2013) for
details. Contrast-based A-learning is distinguished
from the regret-based A-learning methods of Mur-
phy (2003) and Blatt, Murphy and Zhu (2004),
which rely on direct modeling of the regret functions
and are implemented using a different estimating
equation formulation called Iterative Minimization
for Optimal Regimes by Moodie, Richardson and
Stephens (2007).
All of these methods are alternatives to Q -
learning, which involves modeling the full Q -func-
tions. For k =K − 1, . . . ,1, the Q -functions involve
possibly complex relationships, raising concern over
the consequences of model misspecification for es-
timation of the optimal regime. As identifying the
optimal regime depends only on correct specifica-
tion of the contrast or regret functions, A-learning
methods may be less sensitive to mismodeling; see
Sections 5.3 and 6.
Although we consider these methods only in
the case of binary treatment options here, they
may be extended to more than two treatments
at the expense of complicating the formulation;
see Robins (2004) and Moodie, Richardson and
Stephens (2007).
Contrast-based A-learning proceeds as follows.
Posit models Ck(s¯k, a¯k−1;ψk), k = 1, . . . ,K, for the
contrast functions, depending on parameters ψk.
Consider decision K. Let πK(s¯K , a¯K−1) = pr(AK =
1|S¯K = s¯K , A¯K−1 = a¯K−1) be the propensity of re-
ceiving treatment 1 in the observed data as a func-
tion of past history and V˜(K+1)i = Yi. Robins (2004)
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showed that all consistent and asymptotically nor-
mal estimators for ψK are solutions to estimating
equations of the form
n∑
i=1
λK(S¯Ki, A¯(K−1)i){AKi− πK(S¯Ki, A¯(K−1)i)}
× {V˜(K+1)i −AKiCK(S¯Ki, A¯(K−1)i;ψK)(30)
− θK(S¯Ki, A¯(K−1)i)}= 0
for arbitrary functions λK(s¯K , a¯K−1) of the same
dimension as ψK and arbitrary functions θK(s¯K ,
a¯K−1). Assuming that the model CK(s¯K , a¯K−1;ψK)
is correct, if var(Y |S¯K = sk, A¯K−1 = ak−1) is con-
stant, the optimal choices of these functions are
given by λK(s¯K , a¯K−1;ψK) = ∂/∂ψKCK(s¯K , a¯K−1;
ψK) and θK(s¯Ki, a¯(K−1)i) = hK(s¯K , a¯K−1); other-
wise, if the variance is not constant, the optimal λK
is complex (Robins, 2004).
To implement estimation of ψK via (30), one may
adopt parametric models for these functions. Al-
though A-learning obviates the need to specify fully
the Q-functions, one may posit models for the op-
timal θK , hK(s¯K , a¯K−1;βK), say. Moreover, unless
the data are from a SMART study, in which case the
propensities πK(s¯K , a¯K−1) are known, these may be
modeled as πK(s¯K , a¯K−1;φK) (e.g., by a logistic re-
gression). These models are only adjuncts to esti-
mating ψK ; as long as at least one of these models
is correctly specified, (30) will yield a consistent esti-
mator for ψK , the so-called double robustness prop-
erty. In contrast, Q -learning requires correct speci-
fication of all Q -functions; see Section 5.3 and Sec-
tion A.5 of the supplemental article [Schulte et al.
(2014)].
Substituting these models in (30), one solves (30)
jointly in (ψTK , β
T
K , φ
T
K)
T with
n∑
i=1
∂hK(S¯K , A¯K−1;βK)
∂βK
× {V˜(K+1)i −AKiCK(S¯Ki, A¯(K−1)i;ψK)
− hK(S¯Ki, A¯(K−1)i;βK)}= 0
and the usual binary regression likelihood score
equations in φK . We then have d
opt
K (s¯K , a¯K−1;ψK) =
I{CK(s¯K , a¯K−1;ψK)> 0}; as in Q -learning, substi-
tuting ψ̂K yields an estimator for the optimal treat-
ment choice at decision K for a patient with past
history S¯K = sK , A¯K−1 = a¯K−1.
With ψ̂K in hand, the contrast-based A-learning
algorithm proceeds in a backward iterative fashion
to yield ψ̂k, k =K − 1, . . . ,1. At the kth decision,
given models hk(s¯k, a¯k−1;βk) and πk(s¯k, a¯k−1;φk),
one solves jointly in (ψTk , β
T
k , φ
T
k )
T a system of es-
timating equations analogous to those above. The
kth set of equations is based on “optimal re-
sponses” V˜(k+1)i, where, for each i, V˜ki estimates
Vk(S¯ki, A¯(k−1),i). It may be shown (see Section A.3 of
the supplemental article [Schulte et al. (2014)]) that
E(Vk+1(S¯k+1, A¯k)+Ck(S¯k, A¯k−1)[I{Ck(S¯k, A¯k−1)>
0} −Ak]|S¯k, A¯k−1) = Vk(S¯k, A¯k−1). Accordingly, de-
fine recursively V˜ki = V˜(k+1)i+Ck(S¯ki, A¯(k−1)i; ψ̂k)×
[I{Ck(S¯ki, A¯(k−1)i; ψ̂k) > 0} − Aki], k = K,K − 1,
. . . ,1, V˜(K+1)i = Yi. The equations at the kth de-
cision are then
n∑
i=1
λk(S¯ki, A¯(k−1)i;ψk){Aki− πk(S¯ki, A¯(k−1)i;φk)}
× {V˜(k+1)i −AkiCk(S¯ki, A¯(k−1)i;ψk)
− hk(S¯ki, A¯(k−1)i;βk)}= 0,
(31)
n∑
i=1
∂hk(S¯K , A¯K−1;βk)
∂βk
× {V˜(k+1)i −AkiCk(S¯ki, A¯(k−1)i;ψk)
− hk(S¯ki, A¯(k−1)i;βk)}= 0
for a given specification λk(s¯k, a¯k−1;ψk), solved
jointly with the maximum likelihood score equa-
tions for binary regression in φk. It follows that
doptk (s¯k, a¯k−1; ψ̂k) = I{Ck(s¯k, a¯k−1; ψ̂k)> 0}. As abo-
ve, the optimal λk is complex (Robins, 2004); taking
λk(s¯k, a¯k−1;ψk) = ∂/∂ψkCk(s¯k, a¯k−1;ψk) is reason-
able for practical implementation.
Summarizing, the estimated optimal regime d̂optA =
(d̂optA,1, . . . , d̂
opt
A,K) is
d̂optA,1(s1) = d
opt
1 (s1; ψ̂1),
d̂optA,k(s¯k, a¯k−1) = d
opt
k (s¯k, ak−1; ψ̂k),(32)
k = 2, . . . ,K.
How well d̂optA estimates d
opt and hence d(1)opt de-
pends on how close the posited Ck(s¯k, a¯k−1;ψk) are
to the true contrast functions as well as correct spec-
ification of the functions hk or πk.
Henceforth, for brevity, we suppress the descrip-
tor “contrast-based” and refer to the foregoing ap-
proach simply as A-learning.
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5.3 Comparison and Practical Considerations
When K = 1, the Q-function is a model for
E(Y |S1 = s1,A1 = a1). If in Q -learning this model
and the variance model Σ1 in (26) are correctly
specified, then, as above, the form of (26) is opti-
mal for estimating ξ1. Accordingly, even if C1(s1;ψ1)
and h1(s1;β1) are correctly modeled, (31) with
K = 1 is generally not of this optimal form for
any choice λ1(s1;ψ1), and, hence, A-learning will
yield relatively inefficient inference on ψ1 and the
optimal regime. However, if in Q -learning the Q-
function is mismodeled, but in A-learning C1(s1;ψ1)
and π1(s1;φ1) are both correctly specified, then A-
learning will still yield consistent inference on ψ1
and hence the optimal regime, whereas inference on
ξ1 and the optimal regime via Q -learning may be
inconsistent. We assess the trade-off between con-
sistency and efficiency in this case in Section 6. For
K > 1, owing to the complications involved in spec-
ifying optimal estimating equations for Q - and A-
learning, relative performance is not readily appar-
ent; we investigate empirically in Section 6.
In special cases, Q - and A-learning lead to iden-
tical estimators for the Q -function (Chakraborty,
Murphy and Strecher, 2010). For example, this holds
if the propensities for treatment are constant, as
would be the case under pure randomization at each
decision point, and certain linear models are used for
C1(s1;ψ1) and h1(s1;β1); Section A.4 of the supple-
mental article [Schulte et al. (2014)] demonstrates
whenK = 1 and pr(A1 = 1|S1 = s1) does not depend
on s1. See Robins [(2004), page 1999] and Rosen-
blum and van der Laan (2009) for further discus-
sion.
As we have emphasized, for Q -learning, while
modeling the Q-function at decision K is a stan-
dard regression problem with response Y , for deci-
sions k =K−1, . . . ,1, this involves modeling the es-
timated value function, which at decision k depends
on relationships for future decisions k + 1, . . . ,K.
Ideally, the sequence of posited models Qk(s¯k, a¯k; ξk)
should respect this constraint. However, this may be
difficult to achieve with standard regression mod-
els. To illustrate, consider (29), and assume S1, S2
are scalar, where the conditional distribution of
S2 given S1 = s1,A1 = a1 is Normal(K
T
1 γ,σ
2), say,
K1 = (1, s1, a1)
T . Recall that V2(s¯2, a1; ξ2) =H
T
2 β2+
(HT2 ψ2)I(H
T
2 ψ2 > 0), where H
T
2 β2 =K
T
1 β21 + s2β22
and HT2 ψ2 = K
T
1 ψ21 + s2ψ22. Then, if model Q2 in
(29) were correct, from (12), ideally, Q1(s1, a1) =
E{V2(s1, S2, a1; ξ2)|S1 = s1,A1 = a1}. Letting ϕ(·)
and Φ(·) be the standard normal density and cu-
mulative distribution function, respectively, it may
be shown (see Section A.5 of the supplemental arti-
cle [Schulte et al. (2014)]) that
Q1(s1, a1) = E{V2(s1, S2, a1; ξ2)|S1 = s1,A1 = a1}
=KT1 (β21 + γβ22)
+ (KT1 ψ21){1−Φ(η)}(33)
+ψ22{σϕ(η) + (K
T
1 γ){1−Φ(η)}},
η =−KT1 (ψ21/ψ22 + γ)/σ,
taking ψ22 > 0. The true Q1(s1, a1) in (33) is clearly
highly nonlinear and likely poorly approximated by
the posited linear model Q1(s1, a1; ξ1) in (29). For
larger K, this incompatibility between true and as-
sumed models would propagate from K − 1, . . . ,1.
Thus, while using linear models for the Q-functions
is popular in practice, the potential for such mis-
modeling should be recognized.
An approach that may mitigate the risk of mis-
modeling is to employ flexible models for the Q -
functions; Zhao, Kosorok and Zeng (2009) use sup-
port vector regression models. Developments in sta-
tistical learning suggest a large collection of power-
ful regression methods that might be used. Many of
these methods must be tuned in order to balance
bias and variance, a natural approach to which is
to minimize the cross-validated mean squared er-
ror of the Q -functions at each decision point. An
obvious downside is that the final model may be
difficult to interpret, and clinicians may not be will-
ing to use “black box” rules. One compromise is to
fit a simple, interpretable model, such as a decision
tree, to the fitted values of the complex model in or-
der to explore the factors driving the recommended
treatment decisions. This simple model can then be
checked against scientific theory. If it appears sensi-
ble, then clinicians may be willing to use predictions
from the complex model. For discussion, see Craven
and Shavlik (1996).
A-learning represents a middle ground between Q -
learning and these approaches in that it allows for
flexible modeling of the functions hk(s¯k, a¯k−1) while
maintaining simple parametric models for the con-
trast functions Ck(s¯k, a¯k−1). Thus, the resulting de-
cision rule, which depends only on the contrast func-
tion, remains interpretable, while the model for the
response is allowed to be nonlinear. This is also ap-
pealing in that it may be reasonable to expect, based
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on the underlying science, that the relationship be-
tween patient history and outcome is complex while
the optimal rule for treatment assignment is depen-
dent, in a simple fashion, on a small number of vari-
ables. The flexibility allowed by a semiparametric
model also has its drawbacks. Techniques for formal
model building, critique and diagnosis are well un-
derstood for linear models but much less so for semi-
parametric models. Consequently, Q -learning based
on building a series of linear models may be more
appealing to an analyst interested in formal diag-
nostics.
A-learning may have certain advantages for mak-
ing inference under the null hypothesis of no effect of
any treatment regime in D on outcome. For exam-
ple, in a SMART, the propensities are specified by
design, and, under the null, the contrast functions
are identically zero and hence correctly specified.
Thus, A-learning will yield consistent estimators for
the parameters defining the contrast function. See
Robins (2004) and the references in Section 8.
6. SIMULATION STUDIES
We examine the finite sample performance of Q -
and A-learning on a suite of simple test examples
via Monte Carlo simulation. We emphasize that
the methods are straightforward to implement in
more complex settings than those here. To illus-
trate trade-offs between the methods, we begin with
correctly specified models and systematically intro-
duce misspecification of the Q -function, the propen-
sity model and both. We focus here on situations
where the contrast function is correctly specified
to gain insight into impact of other model compo-
nents. Scenarios with a misspecified contrast model
can be constructed to include or exclude the tar-
get dopt, precluding generalizable conclusions. See
Section A.9 of the supplemental article [Schulte
et al. (2014)] and Zhang et al. (2012a, 2012b, 2013)
for simulations involving misspecified contrast func-
tions and Robins (2004), Section 9, for discussion.
In all scenarios, 10,000 Monte Carlo replications
were used, and, for each generated data set, d̂optQ and
d̂optA in (28) and (32) were obtained using the Q -
and A-learning procedures in Sections 5.1 and 5.2.
For simplicity, we consider one (K = 1) and two
(K = 2) decision problems, where, at each deci-
sion point, there are two treatment options coded
as 0 and 1. In all cases, we used Q -functions of
the form Q1(s1, a1; ξ1) = h1(s1;β1) + a1C1(s1;ψ1)
and Q2(s¯2, a¯2; ξ2) = h2(s¯2;a1;β2) + a2C2(s¯2, a1;ψ2)
to represent both true and assumed working mod-
els. With the contrast functions correctly specified,
ψk, k = 1,2, dictate the optimal regime. Thus, as
one measure of performance, we focus on relative
efficiency of the estimators of components of ψk as
reflected by the ratio of Monte Carlo mean squared
errors (MSEs) given by MSE of A-learning/MSE
of Q -learning, so that values greater than 1 fa-
vor Q -learning. Recognizing that E{Y ∗(dopt)} is the
benchmark achievable outcome on average, as a sec-
ond measure, we consider the extent to which the es-
timated regimes d̂optQ and d̂
opt
A achieve E{Y
∗(dopt)}
if followed by the population. Specifically, for regime
d indexed by ψ1 (K = 1) or (ψ
T
1 , ψ
T
2 )
T (K = 2), let
H(d) = E{Y ∗(d)}, a function of these parameters.
Then H(dopt) = E{Y ∗(dopt)} is this function evalu-
ated at the true parameter values, and H(d̂opt) is
this function evaluated at the estimated parameter
values for a given data set, where d̂opt is d̂optQ or
d̂optA . Define R(d̂
opt) = E{H(d̂opt)}/H(dopt), where
the expectation in the numerator is with respect
to the distribution of the estimated parameters in
d̂opt. We refer to R(d̂opt) as the v-efficiency of d̂opt,
as it reflects the extent to which d̂opt achieves the
“value” of the true optimal regime. In Section A.6
of the supplemental article [Schulte et al. (2014)] we
discuss calculation of R(d̂opt).
6.1 One Decision Point
In this and the next section, n = 200. Here, the
observed data are (S1i,A1i, Yi), i = 1, . . . , n. With
expit(x) = ex/(1 + ex), we used the class of genera-
tive models
S1 ∼Normal(0,1),
A1|S1 = s1 ∼ Bernoulli{expit(φ
0
10 + φ
0
11s1
+ φ012s
2
1)},
(34)
Y |S1 = s1,
A1 = a1 ∼Normal{β
0
10 + β
0
11s1+ β
0
12s
2
1
+ a1(ψ
0
10 +ψ
0
11s1),9},
indexed by φ0 = (φ010, φ
0
11, φ
0
12)
T , β0 = (β010, β
0
11, β
0
12)
T ,
ψ0 = (ψ010, ψ
0
11)
T , so that dopt = dopt1 , d
opt
1 (s1) =
I(ψ010 + ψ
0
11s1 > 0). For A-learning, we assumed
models h1(s1;β1) = β10 + β11s1, C1(s1;ψ1) = ψ10 +
ψ11s1, and π1(s1;φ1) = expit(φ10 + φ11s1), and for
Q -learning we used Q1(s1, a1; ξ1) = h1(s1;β1) +
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a1C1(s1;ψ1). These models involve correctly spec-
ified contrast functions and are nested within the
true models, with h1(s1;β1), and hence the Q -
function, correctly specified when β012 = 0. The
propensity model π1(s1;φ1) is correctly specified
when φ012 = 0. To study the effects of misspecifica-
tion, we varied β012 and φ
0
12 while keeping the others
fixed, considering parameter settings of the form
φ0 = (0,−2, φ012)
T , β0 = (1,1, β012)
T , ψ0 = (1,0.5)T .
Correctly specified models. As noted in Section 5.3,
when all working models are correctly specified, Q -
learning is more efficient than A-learning, which for
(34) occurs when β012 = φ
0
12 = 0. Here, the efficiency
of Q-learning relative to A-learning is 1.06 for es-
timating ψ010 and 2.74 for ψ
0
11. Thus, Q-learning is
a modest 6% more efficient in estimating ψ010 but a
dramatic 174% more efficient in estimating ψ011. In-
terestingly, the v-efficiency of the decision rules pro-
duced by the methods is similar, with R(d̂optQ ) = 0.97
and R(d̂optA ) = 0.95, so that inefficiency in estimation
of ψ1 via A-learning does not translate into a regime
of poorer quality than that found by Q -learning.
Misspecified propensity model. Under (34), this
situation corresponds to β012 = 0 and nonzero φ
0
12.
An appeal of A-learning is the double robustness
property noted in Section 5.2, which implies that
ψ1 is estimated consistently when the propensity
model is misspecified provided that the Q -function
is correct. In contrast, Q -learning does not depend
on the propensity model, so its performance is un-
affected. Figure 1 shows the relative efficiency in
estimating ψ010 and ψ
0
11 and the efficiency of d̂
opt
Q
and d̂optA as φ
0
12 varies from −1 to 1. The leftmost
panel shows that there is minimal efficiency gain
by using Q -learning instead of A-learning in esti-
mation of ψ010. From the center panel, Q -learning
yields substantial gains over A-learning for estimat-
ing ψ011. Interestingly, the gain is largest when φ
0
12 =
0, which corresponds to a correctly specified propen-
sity model. Letting π0(s1;φ
0
1) be the true propen-
sity, φ01 = (φ
0
10, φ
0
11, φ
0
12)
T , a possible explanation for
this seemingly contradictory result in this scenario
is that, as |φ012| gets larger, logit{π
0(S1;φ
0
1)}= φ
0
10+
φ011s1 + φ
0
12s
2
1 becomes more profoundly quadratic.
Consequently, the estimator for φ11 in the posited
model π1(s1;φ1) = expit(φ10 + φ11s1) approaches
zero, so that the estimated posited propensity ap-
proaches a constant. Because Q - and A-learning are
algebraically equivalent under constant propensity
here, substituting an estimated propensity that is
nearly constant leads to an estimator very similar to
that from Q -learning. Consequently, empirical effi-
ciency gains decrease as |φ012| →∞. The right panel
of Figure 1 shows a small gain in v-efficiency of d̂optQ
over d̂optA ; both achieve good performance.
See Section A.9 of the supplemental article [Schulte
et al. (2014)] for evidence demonstrating this be-
havior of the propensity score and for further sum-
maries reflecting the relative efficiency of the esti-
mated regimes in all scenarios in this and the next
section.
Misspecified Q-function. This scenario examines
the second aspect of A-learning’s double-robustness,
characterized in (34) by φ012 = 0 and nonzero β
0
12.
Here, A-learning leads to consistent estimation while
Q -learning need not. The left panel of Figure 2
shows that the gain in efficiency using A-learning
is minimal in estimating ψ010. The center panel illus-
trates the bias-variance trade-off associated with Q -
versus A-learning. For β012 far from zero, bias in the
misspecifiedQ -function dominates the variance, and
Fig. 1. Monte Carlo MSE ratios for estimators of components of ψ1 (left and center panels) and efficiencies R(d̂
opt
Q ) and
R(d̂optA ) for estimating the true d
opt (right panel) under misspecification of the propensity model. MSE ratios > 1 favor
Q-learning.
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Fig. 2. Monte Carlo MSE ratios for estimators of components of ψ1 (left and center panels) and efficiencies R(d̂
opt
Q ) and
R(d̂optA ) for estimating the true d
opt (right panel) under misspecification of the Q-function. MSE ratios > 1 favor Q-learning.
A-learning enjoys smaller MSE while, for small val-
ues of β012, variance dominates bias, and Q -learning
is more efficient. The right panel shows that large
bias in the Q -function can lead to meaningful loss
(∼10%) in v-efficiency of d̂optQ relative to d̂
opt
A .
Both propensity model and Q-function misspec-
ified. In our class of generative models (34), this
corresponds to nonzero values of both β012 and φ
0
12.
Rather than vary both values, (e.g., over a grid), we
varied one and chose the other so that it is “equiva-
lently misspecified.” In particular, for a given value
of φ012, we selected β
0
12 = β
0
12(φ
0
12) so that the t-
statistic associated with testing φ012 = 0 in the lo-
gistic propensity model and the t-statistic associ-
ated with testing β012 = 0 in the linear Q -function
would be approximately equal in distribution. Con-
sequently, across data sets, an analyst would be
equally likely to detect either form of misspecifica-
tion. Details of this construction are given in Sec-
tion A.7 of the supplemental article [Schulte et al.
(2014)].
As in the preceding scenario, Figure 3 illustrates
the bias-variance trade-off associated with Q - and
A-learning. For large misspecification, A-learning
provides a large enough reduction in bias to yield
lower MSE; for small misspecification, Q -learning
incurs some bias but reduces the variance enough
to yield lower MSE. From the right panel of the
figure, bias seems to translate into a larger loss in
v-efficiency of the estimators of dopt than variance.
6.2 Two Decision Points
For K = 2, the observed data available to es-
timate dopt = (dopt1 , d
opt
2 ) are (S1i,A1i, S2i,A2i, Yi),
i = 1, . . . , n. For these scenarios, we used a class of
true generative data models that differs from those
of Chakraborty, Murphy and Strecher (2010), Song
et al. (2010) and Laber et al. (2010) only in that S2
is continuous instead of binary; as the model at the
first stage is saturated, this allows correct specifica-
tion of the Q -function at decision 1. The generative
Fig. 3. Monte Carlo MSE ratios for estimators of components of ψ1 (left and center panels) and efficiencies R(d̂
opt
Q ) and
R(d̂optA ) for estimating the true d
opt (right panel) under misspecification of both the propensity model and the Q-function. MSE
ratios > 1 favor Q-learning.
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model is
S1 ∼Bernoulli(0.5),
A1|S1 = s1 ∼ Bernoulli{expit(φ
0
10 + φ
0
11s1)},
S2|S1 = s1,
A1 = a1 ∼Normal(δ
0
10 + δ
0
11s1 + δ
0
12a1 + δ
0
13s1a1,2),
A2|S1 = s1, S2 = s2,
A1 = a1 ∼ Bernoulli{expit(φ
0
20 + φ
0
21s1+ φ
0
22a1
+ φ023s2 + φ
0
24a1s2 + φ
0
25s
2
2)},
Y |S1 = s1, S2 = s2,
A1 = a1,
A2 = a2 ∼Normal{m(s1, s2, a1, a2),10},
m(s1, s2, a1, a2) = β
0
20 + β
0
21s1 + β
0
22a1
+ β023s1a1 + β
0
24s2 + β
0
25s
2
2
+ a2(ψ
0
20 +ψ
0
21a1 + ψ
0
22s2).
The model is indexed by φ01 = (φ
0
10, φ
0
11)
T , δ01 =
(δ010, δ
0
11, δ
0
12, δ
0
13)
T , φ02 = (φ
0
20, φ
0
21, φ
0
22, φ
0
23, φ
0
24, φ
0
25)
T ,
β02 = (β
0
20, β
0
21, β
0
22, β
0
23, β
0
24, β
0
25)
T , and ψ02 = (ψ
0
20, ψ
0
21,
ψ022)
T , with true h02(s1, s2, a1) = β
0
20+β
0
21s1+β
0
22a1+
β023s1a1+β
0
24s2+β
0
25s
2
2 and contrast function C
0
2 (s1,
s2, a1) = ψ
0
20 + ψ
0
21a1 + ψ
0
22s2, say. Because A1
and S1 are binary, the true functions h
0
1(s1) =
β010 + β
0
11s1 and C
0
1 (s1) = ψ
0
10 + ψ
0
11s1 are linear
in s1; β
0
10, β
0
11, ψ
0
10 and ψ
0
11 are derived in terms
of parameters indexing the generative model in
Section A.8 of the supplemental article [Schulte
et al. (2014)]. Thus, the true optimal regime has
dopt1 (s1) = I(ψ
0
10 + ψ
0
11s1 > 0) and d
opt
2 (s1, s2, a1) =
I(ψ020 +ψ
0
21a1 + ψ
0
22s2 > 0).
We assumed working models for A-learning of
the form h1(s1;β1) = β10+β11s1, C1(s1;ψ1) = ψ10+
ψ11s1, π1(s1;φ1) = expit(φ10 + φ11s1), h2(s1, s2, a1;
β2) = β20+β21s1+β22a1+β23s1a1+β24s2, C2(s1, s2,
a1;ψ2) = ψ20+ψ21a1+ψ22s2, and π2(s1, s2, a1;φ2) =
expit(φ20 + φ21s1 + φ22a1 + φ23s2 + φ24a1s2); and,
similarly, Q -functions Q1(s1, a1; ξ1) = h1(s1;β1) +
a1C1(s1;ψ1) and Q2(s1, s2, a1, a2; ξ2) = h2(s1, s2, a1;
β2) + a2C2(s1, s2, a1;ψ2) for Q -learning, so that the
contrast functions are correctly specified in each
case. Comparison of the working and generative
models shows that the former are correctly speci-
fied when φ025 and β
0
25 are both zero and are mis-
specified otherwise. Thus, we systematically varied
these parameters to study the effects of misspecifica-
tion, leaving all other parameter values fixed, taking
φ01 = (0.3,−0.5)
T , δ01 = (0,0.5,−0.75,0.25)
T , φ02 =
(0,0.5,0.1,−1,−0.1, φ025)
T , β02 = (3,0,0.1,−0.5,−0.5,
β025)
T , and ψ02 = (1,0.25,0.5)
T .
Correctly specified models. This occurs when φ025 =
β025 = 0. As discussed previously, Q -learning is effi-
cient when the models are correctly specified. Ef-
ficiencies of Q - learning relative to A-learning for
estimating ψ010, ψ
0
11, ψ
0
20, ψ
0
21 and ψ
0
22 are 1.07, 1.03,
1.19, 1.44 and 1.98, respectively. Hence, Q -learning
is markedly more efficient in estimating the second
stage parameters but only modestly so for first stage
parameters. More efficient estimators of the param-
eters do not translate into greater v-efficiency of the
estimated regimes in this scenario, as R(d̂optQ ) = 0.96
and R(d̂optA ) = 0.96.
Misspecified propensity model. The propensity
model at the second stage is misspecified when φ025
is nonzero. To isolate the effects of such misspeci-
fication, we set β025 = 0 and varied φ
0
25 between −1
and 1. From Figure 4, Q -learning is more efficient
than A-learning for estimation of all parameters in
ψ1 and ψ2, and, as in the one decision case, the ef-
ficiency gain is largest when φ025 = 0, corresponding
to a correctly specified propensity model. From the
lower right panel, there appears to be little differ-
ence in v-efficiency of d̂optQ and d̂
opt
A .
Misspecified Q-function. Under our class of gen-
erative models, the Q -function is misspecified when
β025 is nonzero. We set φ
0
25 = 0 to focus on the effects
of such misspecification. Figure 5 shows that, for the
first stage parameters ψ010 and ψ
0
11, there is little
difference in efficiency between Q - and A-learning.
The upper panels illustrate varying degrees of the
bias-variance trade-off between the methods. In par-
ticular, in estimating ψ022, a small amount of mis-
specification leads to significant bias, and, hence, A-
learning produces a much more accurate estimator,
while, for ψ020, the bias-variance trade-off is present
but attenuated and there is little difference between
Q - and A-learning. In estimation of ψ021, variance
appears to dominate bias, and Q -learning is pre-
ferred for the chosen range of β025 values. From the
lower right panel, relative efficiency for estimating
ψ022 weakly tracks the relative efficiencies of the es-
timated regimes d̂optQ and d̂
opt
A , suggesting that the
efficiency gain for A-learning in estimating ψ022 leads
to improved estimation of dopt.
Both the propensity model and Q-function mis-
specified. This scenario corresponds to nonzero val-
ues of β025 and φ
0
25. Analogous to the one decision
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Fig. 4. Monte Carlo MSE ratios for estimators of components of ψ2 and ψ1 (upper row and lower row left and center panels)
and efficiencies R(d̂optQ ) and R(d̂
opt
A ) for estimating the true d
opt (lower right panel) under misspecification of the propensity
model. MSE ratios > 1 favor Q-learning.
case, we chose pairs (β025, φ
0
25) that are “equivalently
misspecified;” see Section A.7 of the supplemental
article [Schulte et al. (2014)]. From Figure 6, there
is no general trend in efficiency of estimation across
parameters that might recommend one method over
the other. Furthermore, from the lower right panel,
there is little difference in v-efficiency of the es-
timated regimes. One should not expect to draw
broad conclusions, as neither Q - nor A-learning need
be consistent here. Interestingly, despite misspecifi-
cation of both models, d̂optQ and d̂
opt
A still enjoy high
v-efficiency in this scenario.
6.3 Moodie, Richardson and Stephens Scenario
The foregoing simulation scenarios deliberately in-
volve simple models for the Q -functions in order
to allow straightforward interpretation. To investi-
gate the relative performance of the methods in a
more challenging setting, we generated data from a
scenario similar to that in Moodie, Richardson and
Stephens (2007) in which the true contrast functions
are simple yet the Q -functions are complex.
The data generating process used mimics a study
in which HIV-infected patients are randomized to
receive antiretroviral therapy (coded as 1) or not
(coded as 0) at baseline and again at six months,
where the randomization probabilities depend on
baseline and six month CD4 counts. Specifically,
we generated baseline CD4 count S1 ∼Normal(450,
1502), and baseline treatment A1 was then assigned
according to A1|S1 = s1 ∼ Bernoulli{expit(φ
0
10 +
φ011s1)}. We generated six month CD4 count S2,
distributed conditional on S1 = s1,A1 = a1 as
Normal(1.25s1,60
2). Treatment A2 was then gen-
erated according to A2|S1 = s1,A1 = a1, S2 = s2 ∼
Bernoulli{expit(φ020+φ
0
21s2)}. In contrast to the sce-
nario in Moodie, Richardson and Stephens (2007),
this allows all possible treatment combinations. The
outcome Y is CD4 count at one year; following
Moodie, Richardson and Stephens (2007), Y was
generated as Y = Y opt − µ01(S1,A1) − µ
0
2(S1, S2,
A1,A2), where Y
opt|S1 = s1,A1 = a1, S2 = s2,A2 =
a2 ∼ Normal(400 + 1.6s1,60
2). Here, µ01(S1,A1)
and µ02(S1, S2,A1,A2) are the true advantage (re-
gret) functions; we took C01 (s1) = ψ
0
10 + ψ
0
11s1 and
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Fig. 5. Monte Carlo MSE ratios for estimators of components of ψ2 and ψ1 (upper row and lower row left and center panels)
and efficiencies R(d̂optQ ) and R(d̂
opt
A ) for estimating the true d
opt (lower right panel) under misspecification of the Q-functions.
MSE ratios > 1 favor Q-learning.
C02 (s1, s2, a1) = ψ
0
20 + ψ
0
21s2 to be the true contrast
functions, so that, from Section 5.2,
µ01(S1,A1)
(35)
= (ψ010 +ψ
0
11S1){I(ψ
0
10 + ψ
0
11S1 > 0)−A1},
µ02(S1, S2,A1,A2)
(36)
= (ψ020 +ψ
0
21S2){I(ψ
0
20 + ψ
0
21S2 > 0)−A2}.
It follows that the optimal treatment regime dopt =
(dopt1 , d
opt
2 ) has d
opt
1 (s1) = I(ψ
0
10 + ψ
0
11s1 > 0) and
dopt2 (s¯2, a1) = I(ψ
0
20 + ψ
0
21s2 > 0). While the true
contrast functions are linear in ψ0k, k = 1,2, the true
implied h01(s1) and h
0
2(s1, a1, s2) are nonsmooth and
possibly complex.
FollowingMoodie, Richardson and Stephens (2007),
for A-learning, we assumed working models h1(s1;
β1) = β10+β11s1, C1(s1;ψ1) = ψ10+ψ11s1, h2(s1, s2,
a1;β2) = β20 + β21s1 + β22a1 + β23s1a1 + β24s2,
and C2(s1, s2, a1;ψ2) = ψ20 + ψ21s2, and propen-
sity models π1(s1;φ1) = expit(φ10 + φ11s1) and
π2(s1, s2, a1;φ2) = expit(φ20+φ21s2). For Q -learning,
we analogously assumedQ -functionsQ1(s1, a1; ξ1) =
h1(s1;β1) + a1C1(s1;ψ1) and Q2(s1, s2, a1, a2; ξ2) =
h2(s1, s1, a1;β2)+ a2C2(s1, s2, a1;ψ2). Note that the
contrast functions in each case are correctly spec-
ified, as are the propensity models; however, the
Q -functions are misspecified, as the linear models
h1(s1;β1) and h2(s1, s1, a1;β2) are poor approxima-
tions to the complex forms of the true h01(s1) and
h02(s1, s2, a1).
We report results for n = 1000 with φ01 = (φ
0
10,
φ011)
T = (2.0,−0.006)T , φ02 = (φ
0
20, φ
0
21)
T = (0.8,
−0.004)T , ψ01 = (ψ
0
10, ψ
0
11)
T = (250,−1.0)T , and ψ02 =
(ψ020, ψ
0
21)
T = (720,−2.0)T in Table 1. Because the
Q -functions are misspecified, the Q -learning estima-
tors for ψ01 and ψ
0
2 are biased, while those obtained
via A-learning are consistent owing to the double
robustness property. This leads to the dramatic rel-
ative inefficiency of Q -learning reflected by the MSE
ratios. Under the assumed models, the estimated op-
timal regime for Q -learning dictates that, at base-
line, therapy be given to patients with baseline CD4
count less than 199.7, while that estimated using
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Fig. 6. Monte Carlo MSE ratios for estimators of components of ψ2 and ψ1 (upper row and lower row left and center
panels) and efficiencies R(d̂optQ ) and R(d̂
opt
A ) for estimating the true d
opt (lower right panel) under misspecification of both the
propensity models and Q-functions. MSE ratios > 1 favor Q-learning.
A-learning gives treatment to those with baseline
CD4 count less than 249.1, almost perfectly achiev-
ing the true optimal CD4 threshold of 250. Under
the data generative process, using the baseline deci-
sion rule estimated via Q -learning may result in as
many as 4.4% of patients who would receive ther-
apy at baseline under the true optimal regime being
assigned no treatment. Similarly, at the second de-
cision, the estimated optimal regimes obtained by
Table 1
Monte Carlo average (standard deviation) of estimates
obtained via Q- and A-learning and ratio of Monte Carlo
MSE for the Moodie and Richardson scenario;
MSE ratios > 1 favor Q-learning
Parameter
(true value) Q-learning A-learning MSE ratio
ψ010 = 250 154.8 (23.2) 249.1 (18.7) 0.036
ψ011 =−1.0 −0.775 (0.052) −0.998 (0.041) 0.032
ψ020 = 720 507.3 (49.2) 720.3 (48.4) 0.050
ψ021 =−2.0 −1.584 (0.092) −2.001 (0.085) 0.040
Q - and A-learning dictate that therapy be given to
patients with six month CD4 count less than 320.2
and 360.1, respectively. Again, A-learning yields an
estimated threshold almost identical to the optimal
value of 360. Although that obtained via Q -learning
is lower, 4.3% of patients who should receive ther-
apy at six months would not if the estimated six
month rule from Q -learning were followed by the
population.
By Section A.6 of the supplemental article [Schulte
et al. (2014)],H(dopt) = 1120, whereas E{H(d̂optQ )} ≈
1117.1 (estimated standard error 1.3) and
E{H(d̂optA )} ≈ 1119.9 (0.3), so that R(d̂
opt
Q ) and
R(d̂optA ) are virtually equal to one. Thus, although
Q -learning yields poor estimation of parameters in
the contrast functions, loss in v-efficiency of the
estimated optimal regime is negligible. A possible
explanation is as follows. For (35) and (36), some
patients near the true treatment decision boundary
would have C0k(S¯k, A¯k−1), k = 1,2, close to zero.
Thus, even if a regime improperly assigns treat-
ment to these patients, they would experience only
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a small loss in outcome and hence have little effect
on the overall average. For other patients for whom
the true contrast is not close to zero, improper as-
signment could result in considerable degradation of
outcome. Because the proportion of patients receiv-
ing improper assignment is small in this scenario,
the effect of these latter patients on the overall ex-
pected outcome is not substantial, leading to the
relatively good expected outcome under the esti-
mated Q -learning regime.
7. APPLICATION TO STAR*D
Sequenced Treatment Alternatives to Relieve De-
pression (STAR*D) was a randomized clinical trial
enrolling 4041 patients designed to compare treat-
ment options for patients with major depressive dis-
order. The trial involved four levels, where each
level consisted of a 12 week period of treatment,
with scheduled clinic visits at weeks 0, 2, 4, 6, 9,
12. Severity of depression at any visit was assessed
using clinician-rated and self-reported versions of
the Quick Inventory of Depressive Symptomatology
(QIDS) score (Rush et al., 2003), for which higher
values correspond to higher severity. At the end of
each level, patients deemed to have an adequate clin-
ical response to that level’s treatment did not move
on to future levels, where adequate response was de-
fined by 12-week clinician-rated QIDS score ≤ 5 (re-
mission) or showing a 50% or greater decrease from
the baseline score at the beginning of level 1 (suc-
cessful reduction). During level 1, all patients were
treated with citalopram. Patients continuing to level
2 due to inadequate response, conferring with their
physicians, expressed preference to (i) switch or (ii)
augment citalopram and within that preference were
randomized to one of several options: (i) switch: ser-
traline, bupropion, venlafaxine, or cognitive therapy,
or (ii) augment: citalopram plus one of either bupro-
pion, buspirone, or cognitive therapy. Patients ran-
domized to cognitive therapy (alone or augmented
with citalopram) were eligible, in the case of inad-
equate response, to move to a supplementary level
2A and be randomized to switch to bupropion or
venlafaxine. All patients without adequate response
at level 2 (or 2A) continued to level 3 and, depend-
ing on preference to (i) switch or (ii) augment, were
randomized within that preference to (i) switch: mir-
tazepine or nortriptyline or (ii) augment with ei-
ther: lithium or triiodothyronine. Patients without
adequate response continued to level 4, requiring a
switch to tranylcypromine or mirtazepine combined
with venlafaxine (determined by preference). Thus,
although the study involved randomization, it is ob-
servational with respect to the treatment options
switch or augment. For a complete description see
Rush et al. (2004); see Section A.10 of the supple-
mental article [Schulte et al. (2014)] for a schematic
of the design.
To demonstrate formulation of this problem within
the framework of Sections 2 and 3, we take level 2A
to be part of level 2 and consider only levels 2 and
3, calling them stages (decision points) 1 and 2, re-
spectively (K = 2). Some patients in stage 1 without
adequate response dropped out of the study without
continuing to stage 2. Hence, we analyze complete
case data, excluding dropouts, from 795 patients en-
tering stage 1; 330 of these subsequently continued
to stage 2. Let Ak, k = 1,2, be the treatment at stage
k, taking values 0 (augment) or 1 (switch); both op-
tions are feasible for all eligible subjects. Let S10
denote baseline (study entry) QIDS score and S11
denote the most recent QIDS score at the beginning
of stage 1, respectively, so that S1 = (S10, S11)
T is in-
formation available immediately prior to the first de-
cision. Similarly, let S2 be the information available
immediately prior to stage 2; here, S2 is the most
recent QIDS score at the end of stage 1/beginning of
stage 2. Finally, let T be the QIDS score at the end
of stage 2. Because some patients exhibited adequate
response at the end of stage 1 and did not progress
to stage 2, we define the outcome of interest to be
−S2 (negative QIDS score at the end of stage 1) for
patients not moving to stage 2 and −(S2+T )/2 (av-
erage of negative QIDS scores at the end of stages 1
and 2) otherwise. Thus, writing L0 =max(5, S10/2),
Y =−S2I(S2 ≤L0)− (S2+T )I(S2 >L0)/2, the cu-
mulative average negative QIDS score. Thus, this
demonstrates the case where outcome is a function
of accrued information over the sequence of deci-
sions.
From (9), Q2(s¯2, a¯2) = E(Y |S¯2 = s¯2, A¯2 = a¯2) =
−s2{I(s2 ≤ l0) + I(s2 > l0)/2} + E(−T |S¯2 = s¯2,
A¯2 = a¯2, S2 > l0)I(s2 > l0)/2, so that V2(s¯2, a1) =
−s2I(s2 ≤ l0)+{−s2+U2(s¯2, a1)}I(s2 > l0)/2, where
U2(s¯2, a1) = maxa2 E(−T |S¯2 = s¯2,A1 = a1,A2 = a2,
S2 > l0). Thus, from (12),
Q1(s1, a1) = E[−S2I(S2 ≤ l0)
+ {−S2 +U2(s¯2, a1)}I(S2 > l0)/2|
S1 = s1,A1 = a1].
We describe implementation for Q -learning. At
the second decision point, we must posit a model for
Q2(s¯2, a¯2). From the form of Q2(s¯2, a¯2), we need only
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Table 2
STAR*D data analysis results. Asterisks indicate evidence at level of significance 0.05 (0.10) that the main effect (treatment
contrast) parameter is nonzero
Q-learning A-learning
Parameter Estimate 95% CI p-value Estimate 95% CI p-value
Stage 2
β20 −1.46 (−3.47,0.55) −1.47 (−3.49,0.54)
β21 −0.75 (−0.88,−0.61) * −0.75 (−0.88,−0.61) *
β22 1.17 (0.52, 1.81) * 1.17 (0.52, 1.81) *
ψ20 1.10 (0.02, 2.19) * 1.12 (0.03, 2.22) *
Stage 1
β10 −0.62 (−1.94,0.70) −0.30 (−1.69,1.09)
β11 −0.54 (−0.62,−0.45) * −0.55 (−0.64,−0.46) *
β12 −0.08 (−0.60,0.45) 0.10 (−0.46,0.66)
ψ10 1.11 (0.28, 1.94) * 0.73 (−0.18,1.65)
ψ11 1.02 (−0.08,2.11) * 0.44 (−0.83,1.72)
specify a model for E(−T |S¯2 = s¯2, A¯2 = a¯2, S2 > l0);
given the form of the conditioning set, this may be
carried out using only the data from patients moving
to stage 2. Based on exploratory analysis, defining
s22 to be the slope of the QIDS score over stage 1
based on s11 and s2, we took this model to be of
the form β20 + β21s2 + β22s22 + ψ20a2, so that the
posited Q -function is
Q2(s¯2, a¯2; ξ2)
=−s2{I(s2 ≤ l0) + I(s2 > l0)/2}
(37)
+ I(s2 > l0)
× (β20 + β21s2 + β22s22 +ψ20a2)/2,
ξ2 = (β20, β21, β22, ψ20)
T . Under (37), V2(s¯2, a1; ξ2) =
−s2{I(s2 ≤ l0) + I(s2 > l0)/2}+ I(s2 > l0)× {β20 +
β21s2 + β22s22 + ψ20I(ψ20 > 0)}/2, and the “re-
sponses” V˜2,i for use in (27) may then be formed
by substituting the estimate for ξ2. Based on ex-
ploratory analysis, we took the posited Q -function
at the first stage to be Q1(s1, a1; ξ1) = β10+β11s11+
β12s12 + a1(ψ10 + ψ11s12), where s12 is the slope of
the QIDS score prior to stage 1 based on s10 and s11,
and ξ1 = (β10, β11, β12, ψ10, ψ11)
T . For A-learning,
we posited models for the functions hk(s¯k, a¯k−1) and
Ck(s¯k, a¯k−1), k = 1,2, in the obvious way analogous
to those above, and we took the propensity mod-
els to be of the form π2(s¯2, a1;φ2) = expit(φ20 +
φ21s2+φ22s22+φ23a1) and π1(s1;φ1) = expit(φ10+
φ11s11 + φ12s12). Section A.11 of the supplemental
article [Schulte et al. (2014)] presents model diag-
nostics.
The results are given in Table 2. To describe im-
plementation, we consider interactions significant
based on a test at level α= 0.10. At the first stage,
Q -learning suggests a treatment switch for those
with QIDS slope prior to stage 1 greater than −1.09
(obtained by solving 1.11+1.02S12 = 0); A-learning
assigns a treatment switch for those with this QIDS
slope greater than −1.66. At stage 2, the results sug-
gest that all patients should switch and not augment
their existing treatments.
8. DISCUSSION
We have provided a self-contained account of Q -
and A-learning methods for estimating optimal dy-
namic treatment regimes, including a detailed dis-
cussion of the underlying statistical framework in
which these methods may be formalized and of their
relative merits. Our discussion of A-learning is lim-
ited to the case of two treatment options at each
decision. Our simulation studies suggest that, while
A-learning may be inefficient relative to Q -learning
in estimating parameters that define the optimal
regime when the Q -functions required for the lat-
ter are correctly specified, A-learning may offer ro-
bustness to such misspecification. Nonetheless, Q -
learning may have practical advantages in that it
involves modeling tasks familiar to most data ana-
lysts, allowing the use of standard diagnostic tools.
On the other hand, A-learning may be preferred in
settings where it is expected that the form of the de-
cision rules defining the optimal regime is not overly
complex. However, A-learning increases in complex-
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ity with more than two treatment options at each
stage, which may limit its appeal. Interestingly, in
the simulation scenarios we consider, inefficiency
and bias in estimation of parameters defining the
optimal regime does not necessarily translate into
large degradation of average performance of the es-
timated regime for either method.
Although our simple simulation studies provide
some insight into the relative merits of these meth-
ods, there remain many unresolved issues in esti-
mation of optimal treatment regimes. Approaches
to address the challenges of high-dimensional infor-
mation and large numbers of decision points are
required. Existing methods for model selection fo-
cusing on minimization of prediction error may not
be best for developing models optimal for decision-
making. When K is very large, the number of pa-
rameters in the models required for Q - and A-
learning becomes unwieldy. The analyst may wish
to postulate models in which parameters are shared
across decision points; see Robins (2004), Robins,
Orellana and Rotnitzky (2008), Orellana, Rotnitzky
and Robins (2010) and Chakraborty and Moodie
(2012).
In our development, we have invoked a strong
version of the sequential randomization assumption
to simplify supporting arguments. Richardson and
Robins (2013) allow identification of potential out-
comes under possibly weaker assumptions via graph-
ical representations. These authors also extend the
notion of a dynamic treatment regime.
Formal inference procedures for evaluating the un-
certainty associated with estimation of the optimal
regime are challenging due to the nonsmooth nature
of decision rules, which in turn leads to nonregular-
ity of the parameter estimators; see Robins (2004),
Chakraborty, Murphy and Strecher (2010), Laber
et al. (2010), Moodie and Richardson (2010), Song
et al. (2010) and Laber and Murphy (2011).
We have discussed sequential decision-making in
the context of personalized medicine, but many
other applications exist where, at one or more times
in an evolving process, an action must be taken from
among a set of plausible actions. Indeed, Q -learning
was originally proposed in the computer science lit-
erature with these more general problems in mind;
see Shortreed et al. (2011).
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